Screener
AbCellera Biologics Inc. ABCL Retained Earnings
Retained Earnings at other companies
Other financials
Where this comes from
Reported directly by AbCellera Biologics Inc. in its filing.
Tagged under the XBRL concept us-gaap:RetainedEarningsAccumulatedDeficit.
The source filing: AbCellera Biologics Inc.’s 10-Q, filed August 5, 2026. Open the filing →
- Filed
- Aug 5, 2026, 4:28 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001703057-26-000046
FAQ
- What is AbCellera Biologics Inc.'s retained earnings?
- AbCellera Biologics Inc. (ABCL) reported retained earnings of -$128.07M in Q2 2026.
- How has AbCellera Biologics Inc.'s retained earnings changed year-over-year?
- AbCellera Biologics Inc.'s retained earnings decreased by 450.1% year-over-year, from $36.58M to -$128.07M.
- What is the long-term trend for AbCellera Biologics Inc.'s retained earnings?
- Over 5 years (2020 to 2025), AbCellera Biologics Inc.'s retained earnings has grown at a -23.7% compound annual growth rate (CAGR), from $114.2M to -$29.48M.
- What does retained earnings mean?
- Cumulative net income earned since inception minus all dividends paid — the total profits reinvested in the business over its lifetime.
Ask your AI about AbCellera Biologics Inc.'s retained earnings.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude